Acadia Pharmaceuticals buy HC Wainwright
Start price
28.02.24
/
50%
€21.80
Target price
28.02.25
€30.43
Performance (%)
-28.37%
Price
26.04.24
€15.62
Summary
This prediction is currently active. The price of Acadia Pharmaceuticals has decreased since the start of the prediction. Compared to the start price this results in a performance of -28.37%. This prediction currently runs until 28.02.25. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Acadia Pharmaceuticals | 0.807% | 0.807% |
| iShares Core DAX® | -0.992% | -3.231% |
| iShares Nasdaq 100 | -0.225% | -3.339% |
| iShares Nikkei 225® | -0.736% | -7.859% |
| iShares S&P 500 | -0.509% | -2.979% |
Comments by HC_Wainwright for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $33.00 price target on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by HC_Wainwright for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€25.60
03.08.23
03.08.23
€30.16
03.08.24
03.08.24
-39.00%
26.04.24
26.04.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€26.40
14.07.23
14.07.23
€29.39
14.07.24
14.07.24
-40.85%
26.04.24
26.04.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€19.63
28.02.23
28.02.23
€23.50
28.02.24
28.02.24
12.07%
29.02.24
29.02.24